Twist Bioscience Corporation Other Comprehensive Income (Loss), Net of Tax
Twist Bioscience Corporation (TWST) reported Other Comprehensive Income (Loss), Net of Tax of -$16.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-03
- Twist Bioscience Corporation other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$16.00K.
- Twist Bioscience Corporation other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$68.00K.
- Twist Bioscience Corporation other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $56.00K.
- Twist Bioscience Corporation other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $237.00K, a 11.27% increase year-over-year.
- Twist Bioscience Corporation other comprehensive income (loss), net of tax for fiscal 2025 was -$105.00K, a 144.87% decline from fiscal 2024.
- Twist Bioscience Corporation other comprehensive income (loss), net of tax for fiscal 2024 was $234.00K, a 78.47% decline from fiscal 2023.
- Twist Bioscience Corporation other comprehensive income (loss), net of tax for fiscal 2023 was $1.09M.
- Twist Bioscience Corporation other comprehensive income (loss), net of tax for fiscal 2022 was -$2.39M, a 620.48% decline from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$16.00K 10-Q · filed 2026-08-03 | -$84.00K derived: sum of 2 quarters · filed 2026-08-03 | -$28.00K 10-Q · filed 2026-08-03 | $209.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$68.00K 10-Q · filed 2026-05-04 | -$12.00K 10-Q · filed 2026-05-04 | $225.00K derived: sum of 3 quarters · filed 2026-05-04 | $23.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $56.00K 10-Q/A · filed 2026-02-26 | $293.00K derived: sum of 2 quarters · filed 2026-02-26 | $91.00K derived: sum of 3 quarters · filed 2026-08-03 | $78.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-09-30 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-17 | $35.00K derived: sum of 2 quarters · filed 2026-08-03 | $22.00K derived: sum of 3 quarters · filed 2026-08-03 | -$105.00K 10-K · filed 2025-11-17 |
| 2025-06-30 | -$202.00K 10-Q · filed 2026-08-03 | -$215.00K derived: sum of 2 quarters · filed 2026-08-03 | -$342.00K 10-Q · filed 2026-08-03 | -$129.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$13.00K 10-Q · filed 2026-05-04 | -$140.00K 10-Q · filed 2026-05-04 | $73.00K derived: sum of 3 quarters · filed 2026-05-04 | -$2.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$127.00K 10-Q/A · filed 2026-02-26 | $86.00K derived: sum of 2 quarters · filed 2026-02-26 | $11.00K derived: sum of 3 quarters · filed 2026-02-26 | -$84.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-09-30 | $213.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-17 | $138.00K derived: sum of 2 quarters · filed 2025-11-17 | $43.00K derived: sum of 3 quarters · filed 2025-11-17 | $234.00K 10-K · filed 2025-11-17 |
| 2024-06-30 | -$75.00K 10-Q · filed 2025-08-04 | -$170.00K derived: sum of 2 quarters · filed 2025-08-04 | $21.00K 10-Q · filed 2025-08-04 | -$100.00K derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-03-31 | -$95.00K 10-Q · filed 2025-05-05 | $96.00K 10-Q · filed 2025-05-05 | -$25.00K derived: sum of 3 quarters · filed 2025-11-17 | -$771.00K derived: sum of 4 quarters · filed 2025-11-17 |
| 2023-12-31 | $191.00K 10-Q · filed 2025-02-03 | $70.00K derived: sum of 2 quarters · filed 2025-11-17 | -$676.00K derived: sum of 3 quarters · filed 2025-11-17 | $44.00K derived: sum of 4 quarters · filed 2025-11-17 |
| 2023-09-30 | -$121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-17 | -$867.00K derived: sum of 2 quarters · filed 2025-11-17 | -$147.00K derived: sum of 3 quarters · filed 2025-11-17 | $1.09M 10-K · filed 2025-11-17 |
| 2023-06-30 | -$746.00K 10-Q · filed 2024-08-02 | -$26.00K derived: sum of 2 quarters · filed 2024-08-02 | $1.21M 10-Q · filed 2024-08-02 | $742.00K derived: sum of 4 quarters · filed 2024-11-18 |
| 2023-03-31 | $720.00K 10-Q · filed 2024-05-02 | $1.95M 10-Q · filed 2024-05-02 | $1.49M derived: sum of 3 quarters · filed 2024-11-18 | $586.00K derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-12-31 | $1.23M 10-Q · filed 2024-02-02 | $768.00K derived: sum of 2 quarters · filed 2024-11-18 | -$134.00K derived: sum of 3 quarters · filed 2024-11-18 | -$972.00K derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-09-30 | -$466.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-18 | -$1.37M derived: sum of 2 quarters · filed 2024-11-18 | -$2.21M derived: sum of 3 quarters · filed 2024-11-18 | -$2.39M 10-K · filed 2024-11-18 |
| 2022-06-30 | -$902.00K 10-Q · filed 2023-08-07 | -$1.74M derived: sum of 2 quarters · filed 2023-08-07 | -$1.92M 10-Q · filed 2023-08-07 | -$1.80M derived: sum of 4 quarters · filed 2023-11-21 |
| 2022-03-31 | -$838.00K 10-Q · filed 2023-05-08 | -$1.02M 10-Q · filed 2023-05-08 | -$903.00K derived: sum of 3 quarters · filed 2023-11-21 | -$665.00K derived: sum of 4 quarters · filed 2023-11-21 |
| 2021-12-31 | -$183.00K 10-Q · filed 2023-02-07 | -$65.00K derived: sum of 2 quarters · filed 2023-11-21 | $173.00K derived: sum of 3 quarters · filed 2023-11-21 | $221.00K derived: sum of 4 quarters · filed 2023-11-21 |
| 2021-09-30 | $118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-21 | $356.00K derived: sum of 2 quarters · filed 2023-11-21 | $404.00K derived: sum of 3 quarters · filed 2023-11-21 | $459.00K 10-K · filed 2023-11-21 |
| 2021-06-30 | $238.00K 10-Q · filed 2022-08-08 | $286.00K derived: sum of 2 quarters · filed 2022-08-08 | $341.00K 10-Q · filed 2022-08-08 | $294.00K derived: sum of 4 quarters · filed 2023-06-05 |
| 2021-03-31 | $48.00K 10-Q · filed 2022-05-06 | $103.00K 10-Q · filed 2022-05-06 | $56.00K derived: sum of 3 quarters · filed 2023-06-05 | -$23.00K derived: sum of 4 quarters · filed 2023-06-05 |
| 2020-12-31 | $55.00K 10-Q · filed 2022-02-09 | $8.00K derived: sum of 2 quarters · filed 2023-06-05 | -$71.00K derived: sum of 3 quarters · filed 2023-06-05 | -$48.00K derived: sum of 4 quarters · filed 2023-06-05 |
| 2020-09-30 | -$47.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-05 | -$126.00K derived: sum of 2 quarters · filed 2023-06-05 | -$103.00K derived: sum of 3 quarters · filed 2023-06-05 | -$94.00K 10-K/A · filed 2023-06-05 |
| 2020-06-30 | -$79.00K 10-Q · filed 2021-08-09 | -$56.00K derived: sum of 2 quarters · filed 2021-08-09 | -$47.00K 10-Q · filed 2021-08-09 | $17.00K derived: sum of 4 quarters · filed 2021-11-23 |
| 2020-03-31 | $23.00K 10-Q · filed 2021-05-07 | $32.00K 10-Q · filed 2021-05-07 | $96.00K derived: sum of 3 quarters · filed 2021-11-23 | $349.00K derived: sum of 4 quarters · filed 2021-11-23 |
| 2019-12-31 | $9.00K 10-Q · filed 2021-02-09 | $73.00K derived: sum of 2 quarters · filed 2021-11-23 | $326.00K derived: sum of 3 quarters · filed 2021-11-23 | $166.00K derived: sum of 4 quarters · filed 2021-11-23 |
| 2019-09-30 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-23 | $317.00K derived: sum of 2 quarters · filed 2021-11-23 | $157.00K derived: sum of 3 quarters · filed 2021-11-23 | $94.00K 10-K · filed 2021-11-23 |
| 2019-06-30 | $253.00K 10-Q · filed 2020-08-12 | $93.00K derived: sum of 2 quarters · filed 2020-08-12 | $30.00K 10-Q · filed 2020-08-12 | $49.00K derived: sum of 4 quarters · filed 2020-11-27 |
| 2019-03-31 | -$160.00K 10-Q · filed 2020-05-13 | -$223.00K 10-Q · filed 2020-05-13 | -$204.00K derived: sum of 3 quarters · filed 2020-11-27 | -$190.00K derived: sum of 4 quarters · filed 2020-11-27 |
| 2018-12-31 | -$63.00K 10-Q · filed 2020-02-10 | -$44.00K derived: sum of 2 quarters · filed 2020-11-27 | -$30.00K derived: sum of 3 quarters · filed 2020-11-27 | -$18.00K derived: sum of 4 quarters · filed 2020-11-27 |
| 2018-09-30 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-27 | $33.00K derived: sum of 2 quarters · filed 2020-11-27 | $45.00K derived: sum of 3 quarters · filed 2020-11-27 | $54.00K 10-K · filed 2020-11-27 |
| 2018-06-30 | $14.00K 10-Q · filed 2019-08-09 | $26.00K derived: sum of 2 quarters · filed 2019-08-09 | $35.00K 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $12.00K 10-Q · filed 2019-05-02 | $21.00K 10-Q · filed 2019-05-02 | ||
| 2017-12-31 | $9.00K 10-Q · filed 2019-02-11 | |||
| 2017-09-30 | $24.00K 10-K · filed 2019-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |